A Case of Unresectable Papillary Thyroid Carcinoma Treated with Lenvatinib as Neoadjuvant Chemotherapy
A 75-year-old woman visited a nearby clinic with complaints of right clavicle discomfort, and she underwent diagnostic thoracoscopic lung biopsy, being diagnosed with lung metastasis and a right-upper mediastinal mass. The superior mediastinum mass was extrapulmonary and covered by the pleura, and i...
Saved in:
Main Authors: | Hiroyuki Iwasaki, Soji Toda, Hiroyuki Ito, Daiji Nemoto, Daisuke Murayama, Yoichiro Okubo, Hiroyuki Hayashi, Tomoyuki Yokose |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2020/6438352 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thyroid-Associated Ophthalmopathy after Radioactive Iodine Therapy for Metastatic Follicular Thyroid Carcinoma
by: Daisuke Murayama, et al.
Published: (2021-01-01) -
The frequency of mutations in advanced thyroid cancer in Japan: a single-center study
by: Soji Toda, et al.
Published: (2024-01-01) -
Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
by: Ai Matsui, et al.
Published: (2022-01-01) -
Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice
by: V. V. Petkau, et al.
Published: (2022-12-01) -
Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis
by: Lingling Zhao, et al.
Published: (2025-02-01)